synonym
term
coronaviru
typic
use
conjunct
speci
design
exampl
miniopteru
bat
human
sever
acut
respiratori
syndromerel
coronaviru
sarscov
aggress
human
coronaviru
known
date
epidemiolog
quit
differ
fi
nonsar
human
coronavirus
novemb
juli
sarscov
emerg
swept
around
globe
via
rout
intern
air
travel
caus
sar
case
countri
death
strain
healthcar
system
countri
infect
led
travel
restrict
signifi
cant
effect
global
economi
juli
declar
chain
persontoperson
transmiss
sarscov
epidem
broken
sinc
juli
sar
infect
document
sever
occas
three
incid
attribut
breach
laboratori
biosafeti
fourth
incid
involv
four
communityacquir
case
attribut
anim
environment
exposur
three
undetermin
sourc
infect
fourth
liang
et
al
contrast
nonsar
human
coronavirus
continu
circul
global
sinc
initi
isol
emerg
winter
spring
demonstr
period
epidem
occur
year
interv
primarili
caus
upper
respiratori
tract
infect
common
children
adult
account
estim
adult
cold
upper
respiratori
tract
infect
peak
viral
activ
less
commonli
associ
lower
respiratori
tract
diseas
infant
immunocompromis
patient
elderli
gerna
et
al
principi
et
al
van
der
hoek
late
hcovemc
isol
male
present
acut
pneumonia
subsequ
develop
renal
failur
fatal
outcom
zaki
et
al
discoveri
midseptemb
hcovemc
renam
merscov
de
groot
caus
laboratoryconfi
rmed
case
sever
acut
pneumonia
includ
death
sarscov
anim
viru
cross
speci
barrier
environment
chang
increas
chanc
viru
enter
human
enabl
humantohuman
transmiss
antia
et
al
support
research
identifi
ed
sarscovlik
viru
himalayan
mask
palm
civet
raccoon
dog
chines
ferret
badger
sold
liveanim
market
human
consumpt
southern
china
well
human
work
market
indic
rout
interspeci
transmiss
horsesho
bat
identifi
ed
natur
reservoir
sarscovlik
virus
guan
et
al
li
et
al
song
et
al
sarscov
highli
contagi
spread
occur
primarili
close
persontoperson
contact
via
droplet
transmiss
fomit
viru
shed
respiratori
secret
fece
urin
room
temperatur
retain
infect
day
diarrheal
stool
sampl
day
dri
day
respiratori
specimen
viru
readili
inactiv
commonli
use
disinfect
lai
et
al
rabenau
et
al
coronavirus
largest
rna
virus
positivesens
singlestrand
rna
genom
kilobas
virion
envelop
spheric
wide
space
clubshap
surfac
project
give
viru
uniqu
coron
fring
negativestain
electron
microscopi
fig
cryoelectron
microscopi
reveal
outer
envelop
diamet
nm
nm
clubshap
surfac
project
except
thick
nm
envelop
loos
wound
helic
nucleocapsid
separ
envelop
nm
gap
certain
structur
protein
common
coronavirus
spike
glycoprotein
envelop
glycoprotein
mediat
receptorbind
membran
fusion
envelop
span
glycoprotein
contribut
thick
envelop
envelop
protein
e
identifi
ed
virul
factor
sarscov
nucleocapsid
protein
n
function
genom
encapsid
rna
synthesi
translat
type
interferon
antagonist
fig
addit
accessori
protein
vari
speci
sarscov
structur
protein
nonstructur
protein
describ
goldsmith
et
al
king
et
al
neuman
et
al
sarscov
intern
bind
spike
glycoprotein
host
cell
surfac
receptor
angiotensinconvert
enzym
wang
et
al
bind
initi
conform
chang
spike
mediat
fusion
viral
host
cell
membran
releas
nucleocapsid
target
cell
allow
disassembl
replic
genom
spikemedi
celltocel
fusion
occur
promot
syncytium
format
viral
spread
cheng
et
al
intern
specifi
c
mechan
human
immun
system
respond
sarscov
well
understood
particular
area
controversi
role
interferon
ifn
cameron
colleagu
measur
plasma
level
ifn
natur
histori
sar
patient
found
high
ifnalpha
ifngamma
ifnstimul
chemokin
level
robust
antivir
ifnstimul
gene
isg
express
present
earli
cours
ill
patient
enter
crisi
phase
start
approxim
day
patient
resolv
ifn
respons
crisi
express
adapt
immun
gene
recov
contrast
patient
poor
outcom
demonstr
deviat
isg
immunoglobulin
gene
express
level
persist
chemokin
level
defi
cient
antisar
spike
antibodi
product
suggest
malfunct
switch
innat
adapt
immun
cameron
et
al
mean
incub
period
sar
day
rang
day
clinic
cours
sar
follow
typic
pattern
parallel
viral
load
fi
rst
week
ill
infl
uenzalik
prodrom
fever
malais
myalgia
headach
rigor
coincid
increas
viral
load
decreas
viral
load
accompani
second
week
ill
character
dri
cough
dyspnea
hypoxemia
patient
develop
larg
volum
wateri
diarrhea
clinic
deterior
rapidli
progress
respiratori
distress
occur
sever
case
approxim
requir
intens
care
progress
respiratori
failur
common
caus
death
transmiss
occur
primarili
second
week
hui
chan
chest
radiograph
ct
chang
occur
day
onset
ill
patient
despit
lack
respiratori
sign
initi
unilater
peripher
area
ground
glass
consolid
progress
multipl
bilater
area
involv
lung
characterist
diffus
alveolar
damag
patient
surviv
acut
episod
traction
bronchiectasi
herald
develop
fi
brosi
honeycomb
lung
fig
chang
et
al
sarscov
affect
multipl
organ
major
patholog
lung
diffus
alveolar
damag
dad
primari
histolog
fi
nding
phase
dad
vari
base
durat
ill
case
short
durat
day
less
demonstr
acutephas
dad
character
hyalin
membran
line
alveolar
wall
interstiti
airspac
edema
mild
chronic
interstiti
infl
ammat
vascular
congest
fig
bronchiolar
injuri
evidenc
lumin
collect
fi
brin
associ
loss
cilia
denud
bronchiolar
epithelium
deposit
fi
brin
expos
basement
membran
case
day
durat
exhibit
organizingphas
dad
character
interstiti
airspac
fi
broblast
prolifer
accompani
repair
includ
type
ii
pneumocyt
hyperplasia
airwaycent
squamou
metaplasia
hyperplast
type
ii
cell
show
mark
cytolog
chang
includ
cytomegali
nucleomegali
clear
nuclear
chromatin
promin
nucleoli
alveolar
space
contain
combin
anteroposterior
portabl
chest
radiograph
center
acquir
day
later
demonstr
consolid
fi
lobe
patient
intub
anteroposterior
chest
radiograph
right
acquir
month
later
demonstr
reticular
opac
lung
peripheri
chest
ct
acquir
time
confi
rm
presenc
fi
brosi
traction
bronchiectasi
reticular
opac
macrophag
desquam
pneumocyt
includ
multinucl
form
acut
bronchopneumonia
common
featur
organizingphas
dad
fi
brin
thrombi
may
also
present
intranuclear
intracytoplasm
inclus
variabl
report
sar
lack
uniqu
tissu
respons
cytopath
effect
make
diagnosi
light
microscopi
alon
difficult
sever
week
progress
organ
phase
fi
brotic
phase
extens
restructur
lung
parenchyma
develop
honeycomb
lung
frank
et
al
clinic
laboratori
fi
nding
reliabl
diagnos
sarscov
infect
earli
rapidli
enough
inform
manag
decis
must
made
soon
patient
enter
healthcar
system
order
contain
potenti
infect
center
diseas
control
prevent
cdc
recommend
diagnosi
sarscov
infect
initi
isol
stringent
infect
control
measur
base
risk
exposur
absenc
persontoperson
transmiss
sarscov
anywher
world
diagnosi
sarscov
infect
consid
patient
requir
hospit
radiolog
confi
rmed
pneumonia
epidemiolog
histori
rais
suspicion
sarscov
infect
suspicion
heighten
patient
within
day
onset
ill
histori
recent
travel
mainland
china
hong
kong
taiwan
close
contact
ill
person
histori
travel
area
employ
occup
risk
sarscov
part
cluster
case
atyp
pneumonia
without
altern
diagnosi
laboratori
test
sarscov
avail
includ
antibodi
detect
enzym
immunoassay
eia
revers
transcript
polymeras
chain
reaction
rtpcr
howev
posit
predict
valu
diagnost
test
low
absenc
persontoperson
transmiss
worldwid
cdc
recommend
test
perform
judici
consult
local
state
health
depart
cdc
initi
sign
symptom
sar
nonspecifi
c
common
gener
wide
differenti
diagnosi
respiratori
pathogen
includ
infl
uenza
viru
parainfl
uenza
fig
acutephas
dad
sar
patient
acutephas
dad
character
eosinophil
hyalin
membran
plaster
alveolar
wall
interstiti
airspac
edema
mild
chronic
interstiti
infl
ammat
hematoxylineosin
stain
virus
respiratori
syncyti
viru
haemophilu
infl
uenza
mycoplasma
pneumonia
chlamydia
speci
legionella
speci
coxiella
burnetii
human
coronavirus
time
write
octob
world
interepidem
period
sar
greatest
risk
recurr
emerg
introduct
sarscov
laboratori
emerg
sarscovlik
virus
wildlif
anim
reservoir
sar
recur
earli
detect
infect
individu
essenti
contain
local
spread
infect
prevent
intern
dissemin
primari
respons
risk
assess
manag
sar
nation
health
author
exampl
cdc
unit
state
howev
role
coordin
global
region
surveil
revis
guidelin
global
surveil
report
sar
provid
framework
activ
nation
intern
level
risk
assess
sar
c
mani
drug
empir
tri
epidem
treatment
shown
consist
improv
outcom
sar
patient
support
medic
care
remain
primari
therapi
case
fatal
ratio
sar
rang
depend
age
group
overal
estim
case
fatal
estim
less
peopl
age
year
younger
year
year
peopl
age
year
older
effort
develop
sar
vaccin
ongo
sinc
epidem
signifi
cant
advanc
made
understand
sarscov
notabl
domain
glycoprotein
allow
viral
infect
identifi
ed
determin
surfac
receptor
bind
glycoprotein
region
interact
glycoprotein
map
present
target
vaccin
develop
howev
much
immunolog
pathogenesi
sar
incomplet
understood
particular
concern
potenti
sar
vaccin
trigger
immunopathogen
mechan
could
lead
sever
diseas
vaccin
observ
veterinari
coronaviru
vaccin
addit
coronavirus
notori
frequent
mutat
complic
develop
suitabl
vaccin
current
licens
vaccin
use
sar
niaid
six
human
coronavirus
recogn
date
sarscov
aggress
four
nonsar
coronavirus
mainli
caus
upper
respiratori
tract
infect
common
children
adult
fi
fth
nonsar
coronaviru
merscov
reportedli
caus
sever
acut
pneumonia
similar
sarscov
sarscov
identifi
ed
etiolog
agent
sar
caus
infect
countri
death
epidem
initi
sign
symptom
sar
nonspecifi
c
common
therebi
gener
wide
differenti
diagnosi
commonli
occur
lower
respiratori
tract
pathogen
sar
primarili
target
lung
produc
viral
pneumonia
high
mortal
rate
dad
histopatholog
hallmark
sar
phase
dad
vari
durat
ill
acutephas
dad
seen
ill
day
less
wherea
organizingphas
dad
associ
ill
greater
day
durat
sar
vaccin
treatment
current
world
interepidem
period
sar
resurg
sar
remain
distinct
possibl
circumst
allow
sarscovlik
viru
cross
speci
barrier
anim
human
liveanim
market
southern
china
still
exist
countri
must
vigil
reemerg
sar
absenc
vaccin
specifi
c
therapi
contain
classic
epidemiolog
procedur
earli
case
detect
isol
infect
control
contact
trace
followup
surveil
remain
tool
contain
local
spread
infect
prevent
intern
dissemin
